Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Intermediate Analysis of A Phase Ii Trial Assessing Gemcitabine and Cisplatin in Locoregional or Metastatic Penile Squamous Cell Carcinoma.

Houédé N, Dupuy L, Fléchon A, Beuzeboc P, Gravis G, Laguerre B, Théodore C, Culine S, Filleron T, Chevreau C.

BJU Int. 2015 Jan 20. doi: 10.1111/bju.13054. [Epub ahead of print]

PMID:
25601543
[PubMed - as supplied by publisher]
2.

[Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer].

Meyer V, Flechon A, Tartas S, Fassi-Fehri H, Ruffion A, Martin X, Colombel M.

Prog Urol. 2015 Feb;25(2):83-9. doi: 10.1016/j.purol.2014.11.001. Epub 2014 Nov 7. French.

PMID:
25482920
[PubMed - in process]
3.

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S.

Lancet Oncol. 2014 Dec;15(13):1442-50. doi: 10.1016/S1470-2045(14)70490-5. Epub 2014 Nov 13.

PMID:
25456363
[PubMed - indexed for MEDLINE]
4.

[Management of testicular teratoma: update by the oncology committee of the French association of urology, external genital organs group (CCAFU-OGE)].

Avances C, Camparo P, Durand X, Flechon A, Murez T, Sebe P, Soulie M, Rigaud J; les membres du CCAFU.

Prog Urol. 2014 Dec;24(16):1050-3. doi: 10.1016/j.purol.2014.07.005. Epub 2014 Sep 8. French.

PMID:
25199728
[PubMed - in process]
5.

Studying the impact of early life exposures to pesticides on the risk of testicular germ cell tumors during adulthood (TESTIS project): study protocol.

Béranger R, Pérol O, Bujan L, Faure E, Blain J, Le Cornet C, Flechon A, Charbotel B, Philip T, Schüz J, Fervers B.

BMC Cancer. 2014 Aug 4;14:563. doi: 10.1186/1471-2407-14-563.

PMID:
25095793
[PubMed - in process]
Free PMC Article
6.

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.

Selle F, Wittnebel S, Biron P, Gravis G, Roubaud G, Bui BN, Delva R, Bay JO, Fléchon A, Geoffrois L, Caty A, Soares DG, de Revel T, Fizazi K, Gligorov J, Micléa JM, Dubot C, Provent S, Temby I, Gaulet M, Horn E, Brindel I, Lotz JP.

Ann Oncol. 2014 Sep;25(9):1775-82. doi: 10.1093/annonc/mdu198. Epub 2014 Jun 3.

PMID:
24894084
[PubMed - in process]
7.

Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review.

Sargos P, Ferretti L, Gross-Goupil M, Orre M, Cornelis F, Henriques de Figueiredo B, Houédé N, Merino C, Roubaud G, Dallaudiére B, Richaud P, Fléchon A.

Prostate Cancer Prostatic Dis. 2014 Sep;17(3):220-6. doi: 10.1038/pcan.2014.17. Epub 2014 May 6.

PMID:
24796290
[PubMed - in process]
8.

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer.

Angelergues A, Maillet D, Fléchon A, Ozgüroglu M, Mercier F, Guillot A, Le Moulec S, Gravis G, Beuzeboc P, Massard C, Fizazi K, de La Motte Rouge T, Delanoy N, Elaidi RT, Oudard S.

Eur J Cancer. 2014 Jun;50(9):1602-9. doi: 10.1016/j.ejca.2014.03.015. Epub 2014 Apr 8.

PMID:
24725337
[PubMed - indexed for MEDLINE]
9.

[Testicular germ cell tumours and early exposures to pesticides: The TESTEPERA pilot study].

Béranger R, Blain J, Baudinet C, Faure E, Fléchon A, Boyle H, Chasles V, Charbotel B, Schüz J, Fervers B.

Bull Cancer. 2014 Mar;101(3):225-35. doi: 10.1684/bdc.2014.1901. French.

PMID:
24691186
[PubMed - indexed for MEDLINE]
10.

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.

Fizazi K, Gravis G, Flechon A, Geoffrois L, Chevreau C, Laguerre B, Delva R, Eymard JC, Rolland F, Houede N, Laplanche A, Burcoveanu D, Culine S.

Ann Oncol. 2014 May;25(5):987-91. doi: 10.1093/annonc/mdu099. Epub 2014 Mar 4.

PMID:
24595454
[PubMed - indexed for MEDLINE]
11.

[CCAFU's contribution to the French National Cancer Institute's reference frame: Adrenal malignant tumors].

Sèbe P, Rigaud J, Avancès C, Brunaud L, Caillard C, Camparo P, Carnaille B, Durand X, Fléchon A, Murez T, Mathonnet M, Triponez F, Mirallié E, Coloby P, Soulié M; Les membres de l’AFCE; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S167-74. doi: 10.1016/S1166-7087(13)70054-X. French.

PMID:
24485291
[PubMed - indexed for MEDLINE]
12.

[CCAFU's contribution to the French National Cancer Institute's reference frame: Retroperitoneal sarcomas].

Avancès C, Rigaud J, Camparo P, Durand X, Sèbe P, Fléchon A, Murez T, Coloby P, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S161-6. doi: 10.1016/S1166-7087(13)70053-8. French.

PMID:
24485290
[PubMed - indexed for MEDLINE]
13.

[CCAFU Recommendations 2013: Testicular germ cell cancer].

Durand X, Rigaud J, Avancès C, Camparo P, Fléchon A, Murez T, Sèbe P, Culine S, Iborra F, Mottet N, Coloby P, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S145-60. doi: 10.1016/S1166-7087(13)70052-6. French.

PMID:
24485289
[PubMed - indexed for MEDLINE]
14.

[CCAFU Recommendations 2013: Penile cancer].

Rigaud J, Avancès C, Camparo P, Durand X, Fléchon A, Murez T, Sèbe P, Coloby P, Culine S, Iborra F, Mottet N, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S135-44. doi: 10.1016/S1166-7087(13)70051-4. French.

PMID:
24485288
[PubMed - indexed for MEDLINE]
15.

Initial management of testicular cancer: practice survey among urologists and pathologists.

Rigaud J, Durand X, Camparo P, Avances C, Culine S, Sebe P, Flechon A, Murez T, Soulie M; Comittee of Cancerology of Association of French Urology (CCAFU).

Clin Genitourin Cancer. 2014 Aug;12(4):292-9. doi: 10.1016/j.clgc.2013.12.002. Epub 2013 Dec 26.

PMID:
24461624
[PubMed - in process]
16.

Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data.

Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, Schüz J, Bray F.

Eur J Cancer. 2014 Mar;50(4):831-9. doi: 10.1016/j.ejca.2013.11.035. Epub 2013 Dec 23.

PMID:
24369860
[PubMed - indexed for MEDLINE]
17.

[Treatment of testicular cancer].

Droz JP, Boyle H, Culine S, Fizazi K, Fléchon A, Massard C.

Bull Cancer. 2013 Dec;100(12):1319-32. doi: 10.1684/bdc.2013.1863. Review. French.

PMID:
24316884
[PubMed - indexed for MEDLINE]
18.

[Chemotherapy in male external genital organs (testicular and penile cancer)].

Deville JL, Flechon A, Bruyère F, Karsenty G, Guy L, Bastide C.

Prog Urol. 2013 Nov;23(15):1265-70. doi: 10.1016/j.purol.2013.08.321. Epub 2013 Oct 2. Review. French.

PMID:
24183085
[PubMed - indexed for MEDLINE]
19.

Sorafenib and sunitinib for elderly patients with renal cell carcinoma.

Derbel Miled O, Dionne C, Terret C, Segura-Ferlay C, Flechon A, Neidhart EM, Negrier S, Droz JP.

J Geriatr Oncol. 2013 Jul;4(3):255-61. doi: 10.1016/j.jgo.2013.04.004. Epub 2013 May 9.

PMID:
24070463
[PubMed - indexed for MEDLINE]
20.

Management of brain metastases from germ cell tumors: a single center experience.

Boyle HJ, Jouanneau E, Droz JP, Fléchon A.

Oncology. 2013;85(1):21-6. doi: 10.1159/000351812. Epub 2013 Jun 29.

PMID:
23816811
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk